AtriCure, Inc. (ATRC) stock
ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.02−0.29 (-0.52%)
Close on Nov 17, 2026Market cap $2.80BP/E 262.0Yield –
AtriCure operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
AtriCure's operating cash flow for the twelve months ending Jun 30, 2026 was $64.94M, up 78.3% year over year. For fiscal 2025 it was $57.33M, up 369.8% from the year before. The highest annual figure on record is $57.33M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.33M | +369.8% |
| FY2024 | Dec 31, 2024 | $12.20M | +172.2% |
| FY2023 | Dec 31, 2023 | $4.48M | – |
| FY2022 | Dec 31, 2022 | -$22.14M | – |
| FY2021 | Dec 31, 2021 | -$13.78M | – |
| FY2020 | Dec 31, 2020 | -$19.87M | – |
| FY2019 | Dec 31, 2019 | -$15.81M | – |
| FY2018 | Dec 31, 2018 | -$4.17M | – |
| FY2017 | Dec 31, 2017 | -$8.94M | – |
| FY2016 | Dec 31, 2016 | -$15.12M | – |
| FY2015 | Dec 31, 2015 | -$7.84M | – |
| FY2014 | Dec 31, 2014 | -$21.60M | – |
| FY2013 | Dec 31, 2013 | -$5.22M | – |
| FY2012 | Dec 31, 2012 | -$1.94M | – |
| FY2011 | Dec 31, 2011 | -$1.99M | – |
| FY2010 | Dec 31, 2010 | -$33.00K | -107.9% |
| FY2009 | Dec 31, 2009 | $419.95K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.19M | +2.7% |
| Q1 FY2026 | Mar 31, 2026 | -$4.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $20.03M | +243.2% |
| Q3 FY2025 | Sep 30, 2025 | $26.72M | +33.6% |
| Q2 FY2025 | Jun 30, 2025 | $21.62M | +192.9% |
| Q1 FY2025 | Mar 31, 2025 | -$11.03M | – |
| Q4 FY2024 | Dec 31, 2024 | $5.84M | +44.8% |
| Q3 FY2024 | Sep 30, 2024 | $20.00M | +1214.3% |
| Q2 FY2024 | Jun 30, 2024 | $7.38M | +145.1% |
| Q1 FY2024 | Mar 31, 2024 | -$21.02M | – |
| Q4 FY2023 | Dec 31, 2023 | $4.03M | +8660.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.52M | – |
| Q2 FY2023 | Jun 30, 2023 | $3.01M | -28.8% |
| Q1 FY2023 | Mar 31, 2023 | -$4.08M | – |
| Q4 FY2022 | Dec 31, 2022 | $46.00K | -84.7% |
| Q3 FY2022 | Sep 30, 2022 | -$1.78M | – |
| Q2 FY2022 | Jun 30, 2022 | $4.23M | – |
| Q1 FY2022 | Mar 31, 2022 | -$24.63M | – |
| Q4 FY2021 | Dec 31, 2021 | $301.00K | -92.4% |
| Q3 FY2021 | Sep 30, 2021 | -$232.00K | -106.1% |
| Q2 FY2021 | Jun 30, 2021 | -$4.53M | – |
| Q1 FY2021 | Mar 31, 2021 | -$9.32M | – |
| Q4 FY2020 | Dec 31, 2020 | $3.95M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.81M | – |
| Q2 FY2020 | Jun 30, 2020 | -$11.55M | -408.3% |
| Q1 FY2020 | Mar 31, 2020 | -$16.09M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.53M | -458.3% |
| Q3 FY2019 | Sep 30, 2019 | -$2.59M | -149.7% |
| Q2 FY2019 | Jun 30, 2019 | $3.75M | – |
| Q1 FY2019 | Mar 31, 2019 | -$13.44M | – |
| Q4 FY2018 | Dec 31, 2018 | $985.00K | -35.5% |
| Q3 FY2018 | Sep 30, 2018 | $5.21M | +3879.4% |
| Q2 FY2018 | Jun 30, 2018 | -$935.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.43M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.53M | +100.8% |
| Q3 FY2017 | Sep 30, 2017 | $131.00K | -87.8% |
| Q2 FY2017 | Jun 30, 2017 | -$1.06M | – |
| Q1 FY2017 | Mar 31, 2017 | -$9.55M | – |
| Q4 FY2016 | Dec 31, 2016 | $761.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $1.08M | – |
See a number that looks wrong?